Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Some supporters claim oral BPC-157 specifically benefits the gut because of its gastric origin, but strong human evidence supporting these claims remains limited
2024;14:617 Fu Z, Gong L, Liu J, Wu J, Barrett EJ, Aylor KW, et al
Abbreviations AT: As-treated CEA: Cost-effectiveness analysis CPI: Consumer price index CVD: Cardiovascular disease GDP: Gross domestic product GLA: Glucose-lowering agent GLP-1RA: GLP-1 receptor agonist HR: Hazard ratio ICER: Incremental cost-effectiveness ratio ITT: Intention-to-treated MACE: Major adverse cardiovascular event NHI: National Health Insurance NHIRD: National Health Insurance Research Database NNT: Number needed to treat OOP: Out-of-pocket QALY: Quality-adjusted life year T2D: Type 2 diabetes WTP: Willingness-to-pay References American Diabetes Association
Jeppesen, Erik Christiansen, Christin L
Iman Bar, M.D
Discontinuation Rates Due to Adverse Events (12mg) TRIUMPH-1's 11.3% is a meaningful improvement over TRIUMPH-4's 18.2%
US$ 20.63
US$ 22.28
US$ 23.47
US$ 25.69
US$ 25.79
